Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate for Regional Anticoagulation in Extended Hemodialysis for AKI
NCT04297839Phase 3Suspended
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of trisodium citrate in extracorporeal circuit thrombosis (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Clotting rate at 8 hours. Started Feb 2019; status: suspended.
02
Drugs
trisodium citrate
03
Conditions
extracorporeal circuit thrombosis
Beyond the preview
Go deeper on NCT04297839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297839.